Israeli pharmaceutical giant Teva has won FDA approval for a growth hormone delivery system developed together with Swiss pharmaceutical company Antares Pharma.
The system combines Teva's top selling Tev-Tropin hormone medication with Antares Pharma's needle-less injector, which works by shooting a very fine stream of fluid through the skin and directly into the fatty tissue beneath.
Teva's hormone medication has been available around the world, including in the US, since 2005, and Antares Pharma's injector has been in use in Europe for several years. But together the two products are expected to quickly become the hormone delivery system of choice in the US, where over $1 billion is spent every year on hormone injections for children.
Want more news from Israel?
Click Here to sign up for our FREE daily email updates